| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/04/2002 | WO2002051381A1 Porous substance and process for producing the same |
| 07/04/2002 | WO2002051380A1 Novel pharmaceutical composition consisting of water-soluble or poorly water-soluble active substances |
| 07/04/2002 | WO2002051379A2 Thixotropic nasal spray |
| 07/04/2002 | WO2002051378A1 Use of fluorinated solvents non-volatile at room temperature in cosmetic or pharmaceutical products |
| 07/04/2002 | WO2002051377A1 Water-in-oil emulsions containing one or more ammonium acryloyl dimethyltaurates or vinyl pyrrolidone copolymers |
| 07/04/2002 | WO2002051356A2 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
| 07/04/2002 | WO2002051259A1 Coated chewing gum products containing various antacids |
| 07/04/2002 | WO2002051258A2 A process for the preparation of medicated chewing gums containing active principles being labile to the humidity |
| 07/04/2002 | WO2002051237A2 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | WO2002030490A3 Fluid material dispensing syringe |
| 07/04/2002 | WO2002026324A3 Tocol-based compositions containing amiodarone |
| 07/04/2002 | WO2002026233B1 Infusion of ciprofloxacin having reduced acid content and being stable in storage |
| 07/04/2002 | WO2002022110A3 Contraception process and administration form for the same |
| 07/04/2002 | WO2002020486A3 Picolinic acid derivatives for the prevention and treatment of cancer in animals |
| 07/04/2002 | WO2002005848A3 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 07/04/2002 | WO2002002716A8 Cubic liquid crystalline compositions and methods for their preparation |
| 07/04/2002 | WO2002002139A3 Methods and composition for oral vaccination |
| 07/04/2002 | WO2002002076A3 Methods for treating inflammation-mediated conditions of the eye |
| 07/04/2002 | WO2001091682A8 Composition and applicator for topical substance delivery |
| 07/04/2002 | WO2001089557A3 Methods for preventing strokes by inducing tolerance to e-selectin |
| 07/04/2002 | WO2001089484A3 Method for increasing the compressibility of poorly binding powder materials |
| 07/04/2002 | WO2001082984A3 Low ionic strength ophthalmic compositions |
| 07/04/2002 | WO2001073431A3 Biomedical assay device |
| 07/04/2002 | WO2001067864A3 Topical virucidal formulation |
| 07/04/2002 | WO2001062257A3 Bupropion metabolites and methods of their synthesis and use |
| 07/04/2002 | WO2001044420A3 Glyceride oil based coating waxes |
| 07/04/2002 | WO2001036007A3 Compositions of a combination of radioactive therapy and cell-cycle inhibitors |
| 07/04/2002 | WO2001032183A3 Pharmaceutical compositions comprising oxcarbazepine |
| 07/04/2002 | WO2000072902A9 Enhanced thawing of biopharmaceutical solutions using oscillatory motion |
| 07/04/2002 | WO2000056266A3 Taste masking coating compositions |
| 07/04/2002 | US20020088019 Methods of and pharmaceutical compositions for improving implantation of embryos |
| 07/04/2002 | US20020086971 Acid end group poly(D,L-lactide-co-glycolide) copolymers with high glycolide content |
| 07/04/2002 | US20020086967 Controlled release polyacrylic acid granules and a process for preparing the same |
| 07/04/2002 | US20020086905 Gel for treatment of skin diseases and for disinfection of the skin |
| 07/04/2002 | US20020086904 Methods of treating affective disorders using derivatives of (-)- venlafaxine |
| 07/04/2002 | US20020086896 Inhibiting stenosis or restenosis following vascular trauma in a mammalian host with cytoskeletal inhibitor comprising taxol, cytochalasin, or an analog thereof; implant coated or embedded with inhibitors for sustained release |
| 07/04/2002 | US20020086878 Monomolecular dispersions of various medicaments prepared for transmucosal delivery; treatment of respiratory illness such as cold and/or allergy |
| 07/04/2002 | US20020086854 Methods and compositions using norastemizole in combination with leukotriene inhibitors |
| 07/04/2002 | US20020086852 Method for treating respiratory disorders associated with pulmonary elastic fiber injury |
| 07/04/2002 | US20020086833 Cocoa procyanidin oligomer/polymer, a polyphenol-type compound; anticancer agent; antioxidant; DNA topoisomerase II enzyme inhibitors, cyclooxygenase, NO (Nitric Oxide) or NO-synthase modulators, nonsteroidal antiinflammatory agent |
| 07/04/2002 | US20020086809 Multifunctional, granulated pellet aid and process |
| 07/04/2002 | US20020086284 Determining sensitivity of a cell to reovirus infection; obtain cells, monitor ras protein signaling, consistent signaling indicates sensitivity to reovirus infection |
| 07/04/2002 | US20020086067 Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses |
| 07/04/2002 | US20020086065 Methods and compositions for the benefit of those suffering from polycystic ovary syndrome with chromium complexes |
| 07/04/2002 | US20020086062 Mixing a mixture comprising a high viscosity fluid and absorbing agent until a dry dispersion is produced; combining, under shear, a combination of the dry dispersion with a naturally derived oil; granulating to produce powder |
| 07/04/2002 | US20020086061 Forming a drug containing core by compressing comprising granulated microparticles of felodipine and cyclodextrin, carrier comprising cyclodextrin particles, a water-insoluble alkaline component and a swellable polymer |
| 07/04/2002 | US20020086060 Process for producing microparticles |
| 07/04/2002 | US20020086059 Dissolving solid material in dimethyl ether under a pressure and heating; reducing pressure on solution to precipitate the solid material as pulverous formulation and to expand dimethyl ether into a gas, separating |
| 07/04/2002 | US20020086057 For therapy of urinary incontinence |
| 07/04/2002 | US20020086056 Tablet containing a coated core |
| 07/04/2002 | US20020086055 Controlled release liquid active agent formulation dosage forms |
| 07/04/2002 | US20020086054 Controlled release system that needs no drilling |
| 07/04/2002 | US20020086053 As antidepressant |
| 07/04/2002 | US20020086052 Rapidly disintegrating methylcellulose tablets |
| 07/04/2002 | US20020086051 For delivering drug directly to interior portions of the body of a mammalian organism, such as to the eye |
| 07/04/2002 | US20020086050 Immunomodulating agent |
| 07/04/2002 | US20020086049 Apoptosis-mimicking synthetic entities and use thereof in medical treatment |
| 07/04/2002 | US20020086048 Design and application method for enhanced oral assimilation through the oral mucosa and/or intestinal membranes, of liquids containing nutrients, nutraceuticals or drugs, which are encapsulated in natural and/or synthetic liposomal vesicles |
| 07/04/2002 | US20020086043 Patch, a kit constituted by a patch and a receptacle and a method |
| 07/04/2002 | US20020086038 Long-lasting styling mousse |
| 07/04/2002 | US20020086030 Preparations and methods for the treatment of t cell mediated diseases |
| 07/04/2002 | US20020086029 For use in inhibiting gastric acid secretion; therapy of gastric acid related diseases |
| 07/04/2002 | US20020086020 Method for improving the half-life of soluble viral receptors on mucosal membranes |
| 07/04/2002 | US20020085990 Osmotic amount of polyethylene glycol (PEG) 3350, or PEG 4000, and a pharmaceutically acceptable effervescent coupling system. |
| 07/04/2002 | US20020085978 Containing a propellant, a cosolvent, and a radical quencher. |
| 07/04/2002 | DE10065047A1 Gelcèmes in Form von O/W-Emulsionen mit einem Gehalt an einem oder mehreren Ammoniumaryloyldimethyltaurat/vinylpyrrolidoncopolymeren Gelcèmes in the form of O / W emulsions with a content of one or more Ammoniumaryloyldimethyltaurat / vinylpyrrolidoncopolymeren |
| 07/04/2002 | DE10065046A1 O/W-Emulsionen mit einem Gehalt an einem oder mehreren Ammonium acryloyldimethyltaurat/Vinylpyrrolidoncopolymeren O / W emulsions containing one or more ammonium acryloyldimethyltaurate / Vinylpyrrolidoncopolymeren |
| 07/04/2002 | DE10065045A1 W/O-Emulsionen mit einem Gehalt an einem oder mehreren Ammoniumacryloyldimethyltaurat/Vinylpyrrolidoncopolymeren W / O emulsions with a content of one or more ammonium acryloyldimethyltaurate / Vinylpyrrolidoncopolymeren |
| 07/04/2002 | DE10064878A1 Verkapselung von Emulsionen Encapsulation of emulsions |
| 07/04/2002 | DE10064453A1 Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen Use of a dopaminergic agent for the treatment of dopaminergic treatable diseases |
| 07/04/2002 | DE10063945A1 Remineralisierende Dental-Klebefolie Remineralizing dental adhesive film |
| 07/04/2002 | CA2433861A1 Controlled release of anti-arrhythmic agents from a biodegradable polyethylene oxide hydrogel for local application to the heart |
| 07/04/2002 | CA2433169A1 Porous substances and methods for producing the same |
| 07/04/2002 | CA2433081A1 Bioactive materials for aneurysm repair |
| 07/04/2002 | CA2432896A1 Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 07/04/2002 | CA2432645A1 Thermoformable solid pharmaceutical composition for controlled release of ivabradine |
| 07/04/2002 | CA2432527A1 Medicinal compositions for oral use |
| 07/04/2002 | CA2432523A1 Compositions of stable t3 and methods of use thereof |
| 07/04/2002 | CA2432518A1 Treatment of inoperable tumors by stereotactic injection of microspheres |
| 07/04/2002 | CA2431910A1 Metered dose inhaler for salmeterol xinafoate |
| 07/04/2002 | CA2431906A1 Process to improve stability of a pharmaceutical composition |
| 07/04/2002 | CA2431415A1 Divalproex sodium dosage forms and a process for their production |
| 07/04/2002 | CA2431375A1 Solid dosage forms of divalproex sodium |
| 07/04/2002 | CA2430930A1 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | CA2429773A1 Aerogel powder comprising therapeutic agents |
| 07/03/2002 | EP1219702A1 Multifunctional granulated pellet aid and process |
| 07/03/2002 | EP1219661A1 Block copolymer having polymer segment derived from oxazoline |
| 07/03/2002 | EP1219604A1 Method for improving the solubility of tricyclic amino alcohol derivatives |
| 07/03/2002 | EP1219298A1 Process for producing protein powder |
| 07/03/2002 | EP1219295A1 Controlled release formulation of valproate |
| 07/03/2002 | EP1219293A2 Pharmaceutical aerosol compostion |
| 07/03/2002 | EP1219292A1 Procedure or manufacturing dry powdered compositions comprising one or several oxygen-containing carotenoids |
| 07/03/2002 | EP1219291A1 Texture masked particles containing an active ingredient |
| 07/03/2002 | EP1218889A2 Controlled release compositions comprising nimesulide |
| 07/03/2002 | EP1218509A2 Fibroblast growth factor-like polypeptides |
| 07/03/2002 | EP1218498A1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 07/03/2002 | EP1218484A1 Elastic article |
| 07/03/2002 | EP1218405A2 Nucleic acid molecule comprising a nucleic acid sequence coding for a hemocyanin |
| 07/03/2002 | EP1218398A1 Antisense modulation of pi3 kinase p110 beta expression |
| 07/03/2002 | EP1218160A1 Process for preparing a foam component |